Status:

COMPLETED

BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study

Lead Sponsor:

RTI Surgical

Conditions:

Anterior Cruciate Ligament Rupture

Eligibility:

All Genders

18-60 years

Brief Summary

To compare the outcome of Anterior Cruciate Ligament (ACL) reconstruction performed using the tibialis allograft to historical outcomes of ACL reconstruction patients and to establish if any correlati...

Detailed Description

This is a single-arm, single site, pilot study in patients with a ruptured ACL. A total of fifty (50) subjects will be enrolled in this trial. All patients will have been scheduled to undergo ACL reco...

Eligibility Criteria

Inclusion

  • Study subjects will be limited to those subjects undergoing allograft anterior cruciate ligament reconstruction surgery
  • Meniscal injuries may be included
  • Isolated, unilateral anterior cruciate ligament injury.
  • All subjects will have a minimum age of eighteen (18) years and a maximum of sixty (60) years.
  • Both male and non-pregnant female subjects will be included.
  • To facilitate follow-up, study subjects will be limited to the local geographic area of the study site and be willing to use the rehabilitation facility and physical therapy schedule assigned by the surgeon.
  • All subjects must be able to read, write, and comprehend instructions and guidelines in English and understand (and sign as an acknowledgment of their understanding) an informed consent declaration.

Exclusion

  • No chondral defects
  • Failure to comply with or meet all of the inclusion criteria listed above.
  • Autograft anterior cruciate ligament surgery on either knee.
  • Anterior cruciate ligament injury on contra-lateral leg at any time
  • Multi-ligament reconstruction
  • Inability to comply with all requirements of this investigation, as well as follow the instructions of the physician.
  • Significant systemic disease or conditions which impact overall health or well being or which necessitate chronic medication use.
  • Revision anterior cruciate ligament surgery to either knee at anytime
  • Exhibiting signs of moderate to severe degenerative joint disease in addition to requiring anterior cruciate ligament surgery.
  • Concomitant injuries to the knee or lower extremities requiring treatment, per surgeon's discretion.

Key Trial Info

Start Date :

November 9 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 9 2017

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00975845

Start Date

November 9 2017

End Date

November 9 2017

Last Update

November 1 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Orthopedic Clinic, Assoc

Phoenix, Arizona, United States, 85016